Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Rom J Morphol Embryol ; 57(2): 407-12, 2016.
Article in English | MEDLINE | ID: mdl-27516012

ABSTRACT

UNLABELLED: The aim of this study is to analyze the immunoexpression of Ki67, p53, MCM3 and PCNA markers in epithelial remnants of dental follicles of impacted teeth and to identify a possible correlation between the immunoexpression of these markers in dentigerous cysts and keratocystic odontogenic tumors in order to evaluate their evolutionary behavior. MATERIALS AND METHODS: A total of 102 cases were included in the study and divided into three subgroups: the first subgroup consisted of 62 cases with dental follicles of impacted teeth, the second included 20 cases of dentigerous cysts and the third subgroup comprised a number of 20 cases with keratocystic odontogenic tumors. Immunomarking with the four antibodies was performed. RESULTS: A positive marking was obtained in over 60% of the dental follicles for all markers. Statistically significant differences were also obtained in dentigerous cysts and keratocystic odontogenic tumors for Ki67, p53 and MCM3. Assessment of the four antibodies in the two layers of keratocystic odontogenic tumors shows a positive correlation between Ki67 and MCM3 both for the basal and parabasal layer, with slightly increased values in the latter. CONCLUSIONS: In order to determine the proliferative capacity of epithelial remnants in the dental follicles, Ki67 and PCNA, Ki67 and MCM3 are the most useful markers in practice; they have similar behavior and are more likely to help in distinguishing between dentigerous cysts and keratocystic odontogenic tumors.


Subject(s)
Dental Sac/metabolism , Dentigerous Cyst/metabolism , Ki-67 Antigen/metabolism , Minichromosome Maintenance Complex Component 3/metabolism , Odontogenic Tumors/metabolism , Proliferating Cell Nuclear Antigen/metabolism , Tooth, Impacted/metabolism , Tumor Suppressor Protein p53/metabolism , Dental Sac/pathology , Dentigerous Cyst/pathology , Humans , Immunohistochemistry , Odontogenic Cysts/metabolism , Odontogenic Cysts/pathology , Odontogenic Tumors/pathology , Tooth, Impacted/pathology
2.
Rom J Morphol Embryol ; 55(1): 43-8, 2014.
Article in English | MEDLINE | ID: mdl-24715164

ABSTRACT

AIM OF THE STUDY: Establishment of Ki67, p53 and CD34 expression in human tooth buds of different stages of odontogenetic development. MATERIALS AND METHODS: Tissue samples containing tooth buds were removed from the incisor areas of human fetuses in different stages of development (weeks 9-10, 12-13, 13-16, 21-24), and from the canine and molar areas of 21-24 weeks fetuses. The tissue fragments were fixed using formalin and were processed using common histological techniques with paraffin embedding. Immunostaining for Ki67, p53 and CD34 has been performed using the dextran method and moist heat antigen retrieval (except for CD34). The resulting slides were photographed and quantitatively evaluated. RESULTS: Ki67 immunoexpression decreases with advancement of the developmental stage of the tooth bud: in the inner enamel epithelium, between weeks 9 and 16 (IEE), in the preameloblasts (PB) between weeks 13 and 16, in the ameloblasts (AB) between weeks 21 and 24; outer enamel epithelium (OEE); stratum intermedium (SI); in the dental papilla: between weeks 9 and 10 in the dental papilla (DP), between weeks 13 and 16 in the outer layer of the dental papilla (DP1) and in the central layer of the dental papilla (DP2). Likewise, we noted Ki67 expression in the odontoblast layer (O) and pulp (P), between weeks 21 and 24. Concerning CD34 expression, we observed a decrease from weeks 9-10 until weeks 13-16, followed by an increase until weeks 21-24 of intrauterine life. From weeks 9-10, we observed a constant decrease of expression until weeks 13-16, followed by an increase during weeks 21-24. CONCLUSIONS: All Ki67, p53 and CD34 have been identified in the tooth bud. Ki67 expression gradually decreases with the embryonic development of the tooth, while p53 and CD34 expression decreases from weeks 9-10 to weeks 13-16 of intrauterine life, followed by an increase until weeks 21-24.


Subject(s)
Antigens, CD34/metabolism , Ki-67 Antigen/metabolism , Tooth Germ/metabolism , Tumor Suppressor Protein p53/metabolism , Humans , Immunohistochemistry , Incisor/cytology , Incisor/metabolism , Tooth Germ/cytology
SELECTION OF CITATIONS
SEARCH DETAIL
...